𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Belatacept: from rational design to clinical application

✍ Scribed by Thomas Wekerle; Josep M. Grinyó

Book ID
110917707
Publisher
Springer
Year
2011
Tongue
English
Weight
413 KB
Volume
25
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib: From Rational Design to Clini
Sunitinib: From Rational Design to Clinical Efficacy
✍ Chow, L. Q.M.; Eckhardt, S. G. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 248 KB

Sunitinib (SU011248) is an oral small molecular tyrosine kinase inhibitor that exhibits potent antiangiogenic and antitumor activity. Tyrosine kinase inhibitors such as SU6668 and SU5416 (semaxanib) demonstrated poor pharmacologic properties and limited efficacy; therefore, sunitinib was rationally

Tyrosine kinase inhibitors: From rationa
Tyrosine kinase inhibitors: From rational design to clinical trials
✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract Protein kinases play a crucial role in signal transduction as well as in cellular proliferation, differentiation, and various regulatory mechanisms. The inhibition of growth related kinases, especially tyrosine kinases, might provide new therapies for diseases such as cancer. The progre

ChemInform Abstract: Tyrosine Kinase Inh
ChemInform Abstract: Tyrosine Kinase Inhibitors: From Rational Design to Clinical Trials.
✍ Peter Traxler; Guido Bold; Elisabeth Buchdunger; Giorgio Caravatti; Pascal Furet 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v